Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Mississippi

33 recruiting clinical trials across 13 cities in Mississippi (MS). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
33
Total Trials
33
Recruiting Now
13
Cities
20
Conditions

Recruiting Trials in Mississippi

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT01915511

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the...

Sponsor: Duke UniversityEnrolling: 300020 locations
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
Age-Related Macular Degeneration
RECRUITINGPhase 2NCT04606914

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant...

The proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EOC. Patients with biopsy...

Sponsor: University of Alabama at BirminghamEnrolling: 709 locations
Ovarian CancerFallopian TubePrimary Peritoneal Cancer
RECRUITINGNCT05087680

An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

Investigators will use a generalized framework for the adaptation of EBIs to inform the development of a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate...

Sponsor: Rhode Island HospitalEnrolling: 661 location
HIV Prevention
RECRUITINGPhase 4NCT05191706

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCUfor the Treatment of Inflammation Following...

Sponsor: EyePoint Pharmaceuticals, Inc.Enrolling: 609 locations
Cataract
RECRUITINGNCT05237466

Motivational Interviewing to Enhance Behavioral Change in Older Adults with Hoarding Disorder

This study will compare two behavioral interventions for hoarding disorder in older adults.

Sponsor: Mississippi State UniversityEnrolling: 601 location
Hoarding Disorder
RECRUITINGPhase 3NCT05261139

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18...

The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after...

Sponsor: PfizerEnrolling: 16020 locations
COVID-19
RECRUITINGPhase 2 / Phase 3NCT05431088

A Phase 2/3 Study in Adult and Adolescent Participants With SCD

The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of osivelotor.

Sponsor: PfizerEnrolling: 38920 locations
Sickle Cell Disease
RECRUITINGPhase 3NCT05568719

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B...

A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who...

Sponsor: PfizerEnrolling: 17316 locations
Hemophilia AHemophilia B
RECRUITINGPhase 3NCT05711394

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants...

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light...

Sponsor: AbbVieEnrolling: 45020 locations
Episodic Migraine
RECRUITINGPhase 2NCT05758246

Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

The long-term goal is to test the clinical efficacy of senolytic therapies to reduce progression to and severity of sepsis in older patients. The central hypothesis is that a...

Sponsor: University of MinnesotaEnrolling: 22010 locations
SepsisAcute InfectionOrgan Failure
RECRUITINGNCT05762705

A Mobile Gaming App to Improve Adherence to PrEP

In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receiving PrEP care in...

Sponsor: Rhode Island HospitalEnrolling: 2003 locations
Medication AdherenceHIV/AIDS
RECRUITINGNCT05787821

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty

Sponsor: Zimmer BiometEnrolling: 76016 locations
Knee Pain ChronicOsteoarthritis, KneeRheumatoid Arthritis+6
RECRUITINGPhase 2 / Phase 3NCT05956626

A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

Phase 2/3 Pivotal Confirmatory Clinical Trial is a randomized, outcome assessor-masked, multicenter study, that will enroll fifty-one (51) subjects. Subjects will be enrolled in a...

Sponsor: OcugenEnrolling: 5114 locations
Stargardt Disease
RECRUITINGPhase 3NCT06091254

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With...

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma...

Sponsor: Regeneron PharmaceuticalsEnrolling: 82220 locations
Follicular Lymphoma (FL)
RECRUITINGNCT06122077

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from...

Sponsor: Freenome Holdings Inc.Enrolling: 2000020 locations
Lung Cancer Diagnosis
RECRUITINGPhase 3NCT06383273

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction...

The goal of this clinical trial is to learn if MELT-300 works on procedural sedation in adult participants undergoing cataract extraction with lens replacement (CELR). It will...

Sponsor: Melt PharmaceuticalsEnrolling: 52812 locations
Cataract
RECRUITINGNCT06387758

Low Systemic/High Local Exercise Load in Peds SCD

This research study wants to learn about what kind of exercise is best for kids with sickle cell disease. Participating children will have a small amount of blood drawn one time...

Sponsor: University of Mississippi Medical CenterEnrolling: 601 location
Sickle Cell Anemia in Children
RECRUITINGPhase 3NCT06439082

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult...

A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without...

Sponsor: Novartis PharmaceuticalsEnrolling: 31520 locations
Sickle Cell Disease
RECRUITINGPhase 3NCT06561386

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for...

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV...

Sponsor: Bristol-Myers SquibbEnrolling: 100020 locations
Non-small Cell Lung Cancer
RECRUITINGPhase 3NCT06672939

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

The main purpose of this study, performed under Master Protocol J4M-MC-PWMP, is to evaluate the efficacy, safety, and pharmacokinetics of orforglipron once daily oral versus...

Sponsor: Eli Lilly and CompanyEnrolling: 12520 locations
ObesityOverweight
RECRUITINGPhase 3NCT06810505

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in...

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea,...

Sponsor: AbbVieEnrolling: 42020 locations
Chronic Migraine
RECRUITINGPhase 3NCT06824467

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard...

The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 77020 locations
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
RECRUITINGPhase 3NCT06898515

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients...

Sponsor: Reprieve Cardiovascular, INCEnrolling: 40020 locations
Acute Decompensated Heart Failure
RECRUITINGNCT06938685

Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers

This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating diabetic foot...

Sponsor: NuScience Medical Biologics, LLCEnrolling: 1325 locations
Diabetic Foot Ulcer
RECRUITINGPhase 3NCT06951711

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder...

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episode of mania or mania...

Sponsor: Bristol-Myers SquibbEnrolling: 27420 locations
Bipolar Disorder Type I With Mania or Mania With Mixed Features
RECRUITINGPhase 3NCT06961968

Randomized Withdrawal Study in Patients With Schizophrenia

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in...

Sponsor: Vanda PharmaceuticalsEnrolling: 40020 locations
Schizophrenia
RECRUITINGPhase 3NCT06975865

The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential study (Part A), followed by an open-label LTE period (Part B) to investigate...

Sponsor: SanofiEnrolling: 19220 locations
Sickle Cell Disease
RECRUITINGPhase 4NCT07089706

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

The purpose of this study is to evaluate the immunogenicity and safety of the recommended variant-containing formulations of mRNA-1283 COVID-19 vaccine (mNEXSPIKE®) within the...

Sponsor: ModernaTX, Inc.Enrolling: 8325 locations
COVID-19
RECRUITINGPhase 2NCT07116746

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase treatment (eg.,...

Sponsor: Arthrosi TherapeuticsEnrolling: 258 locations
GoutGouty ArthritisHyperuricemia+4

Showing 30 of 33 trials in Mississippi. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 33 clinical trials actively recruiting participants in Mississippi. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Mississippi include Sickle Cell Disease, Ovarian Cancer, Primary Peritoneal Cancer, Cataract, COVID-19. Each has multiple active trials across research centers in the state.

Major trial sites in Mississippi include Jackson, Flowood, Gulfport, Ridgeland, Madison. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.